Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation

Published:2014-09 Issue:3 Volume:62 Page:162-166
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Fuentes Eduardo,Palomo Iván

Funder

CONICYT REGIONAL/GORE MAULE/CEAP/R09I2001, Programa de Investigación de Excelencia Interdisciplinaria en Envejecimiento Saludable (PIEI-ES)

Fondecyt, Chile

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference97 articles.

1. et al;Palomo;Rev Med Chil,2007

2. Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey;Bautista;Eur J Cardiovasc Prev Rehabil,2006

3. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology;Grundy;Circulation,1999

4. Intervention with education and exercise reverses the metabolic syndrome in adults;Mujica;J Am Soc Hypertens,2010

5. The platelet in diabetes: focus on prevention of ischemic events;Colwell;Diabetes Care,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor;Thrombosis Research;2024-06

2. Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation;Asian Journal of Pharmaceutical Sciences;2023-01

3. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications;Immunopharmacology and Immunotoxicology;2021-05-31

4. Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention;Genes;2020-09-11

5. Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic;Pharmacology & Therapeutics;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3